本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Roivant Sciences Ltd.

19.87
+0.27001.38%
成交量:1,164.31万
成交额:2.29亿
市值:135.71亿
市盈率:-28.71
高:19.89
开:19.33
低:19.32
收:19.60
52周最高:20.09
52周最低:8.73
股本:6.83亿
流通股本:4.15亿
量比:1.32
换手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):-0.6921
每股收益(LYR):-0.2371
净资产收益率:-18.15%
总资产收益率:-12.59%
市净率:3.12
市盈率(LYR):-83.81

数据加载中...

2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/10

重要事件披露

Form 8-K - Current report
2025/02/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/28

重要事件披露

Form 8-K - Current report
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities